Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 222 of the 223 references it cites were found in a registry or an index; 112 of the 193 sources its claims cite were checked for support.

Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review

Open access

Abstract

Summative review of AI and early detection efforts in pancreatic cancer.

Overview

CoChat Summary

## TL;DR

This is a presummit review and position paper arguing that early detection of pancreatic ductal adenocarcinoma (PDAC) will require risk stratification, better biomarkers/imaging, and substantial use of AI/ML to integrate diverse data sources. It does not report a new empirical study; instead, it synthesizes current efforts, highlights gaps in data and methods, and proposes collaborative structures for future work.

## Key findings

  • PDAC has a poor prognosis: the paper states a 5-year survival rate of 10%, with 49.6% of newly diagnosed cases presenting with distant metastases, 29.1% with regional lymph node involvement, and only 10.8% localized to the pancreas.
  • The paper emphasizes that population-wide screening is unrealistic because baseline risk is low: for U.S. adults 50 years or older, the 3-year baseline risk is 0.11%; higher-risk strata are defined as 0.2%–0.3% (low risk), 0.35%–66% (modest risk, as written), 0.67%–1.0% (high risk), 10×–25× (intermediate high risk), and 3%–4% (very high risk).
  • CA 19-9 remains the only FDA-approved biomarker, but the paper says its sensitivity is only 25% to 50% in early-stage disease and that 5% to 10% of the population lacks the Lewis antigen needed to express it.
  • For a New-Onset Hyperglycemia and Diabetes Cohort, the paper says 10,000 subjects will be recruited and will yield approximately 100 pancreatic cancer cases over 3 years.

## Methods

  • This is a virtual-summit presummit article / comprehensive review, organized into five sections: early detection, AI and machine learning, current efforts, organizational structures, and reflections from government/industry/advocacy.
  • The paper synthesizes information supplied by interdisciplinary participants and by the authors’ identification of ongoing or planned efforts in imaging, blood-based assays, microbiome, patient characteristics, and integrative approaches.
  • The main analysis is narrative and conceptual rather than statistical: it reviews existing studies, funding efforts, data infrastructures, and proposes an “Early Detection Strategy” built around multidisciplinary collaboration and AI/ML-enabled risk models.

## Limitations

  • The paper explicitly states it “should not be considered an exhaustive review of all possible approaches for early detection.”
  • It also states that additional research is being conducted in all areas, indicating the field was evolving and the overview may be incomplete.
  • Evident from the text: this is not an original empirical study, so it does not present new patient-level results, a formal systematic review protocol, or a meta-analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1097/mpa.0000000000001762

Cites

222 of 222 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 Strategic map for innovation (© Kenner Family Research Fund, 2015).
FIGURE 1 Strategic map for innovation (© Kenner Family Research Fund, 2015).CC BY-NC-ND · PubMed Central
FIGURE 2 Survival rates by stage.16
FIGURE 2 Survival rates by stage.16CC BY-NC-ND · PubMed Central
FIGURE 3 Probability of overall survival following surgery.17
FIGURE 3 Probability of overall survival following surgery.17CC BY-NC-ND · PubMed Central
FIGURE 4 Phases of biomarker discovery and validation.7
FIGURE 4 Phases of biomarker discovery and validation.7CC BY-NC-ND · PubMed Central
FIGURE 5 Risk versus prevalence of PDAC. Courtesy of Suresh Chari.
FIGURE 5 Risk versus prevalence of PDAC. Courtesy of Suresh Chari.CC BY-NC-ND · PubMed Central
FIGURE 6 Vision for an early detection protocol. Modified from Kenner et al.6
FIGURE 6 Vision for an early detection protocol. Modified from Kenner et al.6CC BY-NC-ND · PubMed Central
FIGURE 7 Timeline of changes on CT scan in prediagnostic PDAC.72
FIGURE 7 Timeline of changes on CT scan in prediagnostic PDAC.72CC BY-NC-ND · PubMed Central
FIGURE 8 Learning to classify images of dogs versus cats. A, Initial model guess. B, The refined estimate after measuring its performance on the reference set. Courtesy of Adam Yala.
FIGURE 8 Learning to classify images of dogs versus cats. A, Initial model guess. B, The refined estimate after measuring its performance on the reference set. Courtesy of Adam Yala.CC BY-NC-ND · PubMed Central
FIGURE 9 Disease progression over the life course. The figure illustrates how diseases follow each other and how different patients develop different complications to the same disease over time. Events in early disease-free periods will in many cases influence disease risks and disease severity later in life. Big data disease analytics aim at finding such early events and symptoms with predictive value in relation to early diagnosis of for example pancreatic cancer. Courtesy of Jessica Xin Hjaltelin, University of Copenhagen.
FIGURE 9 Disease progression over the life course. The figure illustrates how diseases follow each other and how different patients develop different complications to the same disease over time. Events in early disease-free periods will in many cases influence disease risks and disease severity later in life. Big data disease analytics aim at finding such early events and symptoms with predictive value in relation to early diagnosis of for example pancreatic cancer. Courtesy of Jessica Xin Hjaltelin, University of Copenhagen.CC BY-NC-ND · PubMed Central
FIGURE 10 Early detection strategy. Courtesy of participants from Collaborative Opportunities and Kenner Family Research Fund.
FIGURE 10 Early detection strategy. Courtesy of participants from Collaborative Opportunities and Kenner Family Research Fund.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

55 Valid · 32 Not valid · 57 Not checked · 94 Own results and interpretations

90 more claims · 32 with their cited sources checked

Create a free account to see all 238 claims and to verify the 21 references still open.

See all claims — free account
  • Probably not a substantial claim. 97
  • It may state two separate claims as one. 75

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 223 references

Research works printed but not linked: 2

  1. 2015, Screening familial pancreatic cancer (FPC). Supplemental Digital Content 1. In: Chari ST, Kelly K, Hollingsworth MA, et al. Early detection of sporadic pancreatic cancer: summative review, Pancreas, 44, 693
  2. 2018, A reductions approach to fair classification. Proceedings of the 35th International Conference on Machine Learning, PMLR, 80, 60

Cited by

See all 160

Metadata

Authors
Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., Andersen, D. K., Bernstein, D., Brunak, S., Canto, M. I., Eldar, Y. C., Fishman, E. K., Fleshman, J., Go, V. L. W., Holt, J. M., Field, B., Goldberg, A., Hoos, W., Iacobuzio-Donahue, C., Li, D., Lidgard, G., Maitra, A., Matrisian, L. M., Poblete, S., Rothschild, L., Sander, C., Schwartz, L. H., Shalit, U., Srivastava, S., & Wolpin, B.
Affiliations
  • Kenner Family Research Fund, New York, NY
  • The University of Texas MD Anderson Cancer Center (US)
  • Edward S. Gordon Chair in Medical Oncology
  • Memorial Sloan Kettering Cancer Center (US)
  • Cedars-Sinai Medical Center (US)
  • Dana-Farber Cancer Institute (US)
  • Columbia University Irving Medical Center (US)
  • Google Health, Seattle, WA
  • Division of Genomic Medicine, Department of Medicine, Icahn School of Medicine, Mount Sinai, New York, NY
  • University of Copenhagen (DK)
  • Johns Hopkins University (US)
  • David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY
  • Exact Sciences (United States) (US)
  • Harvard University (US)
  • NewYork–Presbyterian Hospital (US)
  • Technion – Israel Institute of Technology (IL)
Corresponding author
  • Kenner, Barbara
  • Taylor, James A.
  • Canto, Marcia Irene
  • Field, Bruce
  • Goldberg, Ann
  • Rothschild, Laura
  • Shalit, Uri
Venue
Pancreas
Published
2021-03
Volume
50
Issue
3
Pages
251-279
ISSN
  • 0885-3177 (ISSN-L)
  • 1536-4828
OpenAlex
W3147514193
Cited by
158
References
223
Citations by year
2026: 19 · 2025: 35 · 2024: 36 · 2023: 31 · 2022: 29 · 2021: 8
FWCI
1.88
Type
journal article
Language
en
Open access
Locations
  • Pancreas (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
Funders
  • Memorial Sloan-Kettering Cancer Center
  • Cedars-Sinai Medical Center
  • University of Texas MD Anderson Cancer Center
  • Irving Medical Center, Columbia University
  • National Cancer Institute (P01CA236585, P01CA233452, U01CA210171)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
pancreatic cancer, early detection, artificial intelligence, machine learning, risk stratification, multidisciplinary collaboration, research funding
MeSH terms
Artificial Intelligence, Humans, Pancreatic Neoplasms, Prognosis, Biomarkers, Tumor, Survival Analysis, Carcinoma, Pancreatic Ductal, Genomics, Interdisciplinary Communication, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review. https://app.cochat.ai/papers/10.1097/mpa.0000000000001762
The paper
Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., Andersen, D. K., Bernstein, D., Brunak, S., Canto, M. I., Eldar, Y. C., Fishman, E. K., Fleshman, J., Go, V. L. W., Holt, J. M., . . . Wolpin, B. (2021). Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review. Pancreas. https://doi.org/10.1097/mpa.0000000000001762

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.